Efficacy of Zoledronic Acid in Osteoporosis

• Status: Recruiting
• Trial end date: 2025-06-08
• Target enrollment: 0
• Participant gender: All

Summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shinshu University
• Treatments: Alfacalcidol; Diphosphonates; Hydroxycholecalciferols; Vitamin D; Zoledronic Acid

Criteria

Inclusion Criteria:

• Osteoporotic patients who want to take zoledronic acid

Exclusion Criteria:

• Patients who are allergic to zoledronic acid or vitamin D

• Patients who are pregnant or breast-feeding

• Patients who have not taken zoledronic acid for the last 2 years